AGP Executive Report

Cycling Safety: A new study finds cycling in Switzerland is about twice as dangerous as in the Netherlands, with higher accident risk at public transport stops, tram tracks and junctions. Sepsis Awareness: Switzerland’s Sepsis Programme says around 20,000 sepsis cases are recorded in hospitals each year, with about 4,000 deaths—prompting a push for faster recognition and support via a new Sepsis Switzerland association. Nutrition for Headaches: Coverage highlights a prevention-first approach to chronic headaches, pointing to magnesium and riboflavin (B2), hydration, steady blood sugar, and anti-inflammatory foods—while stressing that triggers can be personal. Drug Trial Shock for Swiss Pharma: Novartis’ Lp(a)-lowering drug pelacarsen failed to reduce major cardiovascular outcomes, sending Novartis shares down in Swiss trading and adding pressure after another late-stage setback. Public Health Research: ETH Zürich researchers report a directional-freezing method that can turn lentils, peas and beans into fibrous, meat-like textured proteins. Road Crash Update: After a fatal Swiss Alps bus crash involving Dutch travellers, repatriations are underway and some passengers are expected to return to the Netherlands. Prenatal Medication Concern: A Danish study links prenatal acetaminophen (Tylenol) exposure to smaller ovarian and uterine development in daughters, urging longer-term follow-up.

Prenatal medicine alert: A Danish study reports that girls exposed to Tylenol/acetaminophen in the womb had smaller ovaries and uteruses and fewer ovarian follicles, raising questions about long-term fertility; researchers stress women shouldn’t panic but call for longer follow-up. Heart-health food shift: A new nutrition roundup argues for “protective” eating patterns—highlighting black beans, edamame, Swiss chard, carrots and plant sterols—to support LDL, blood pressure and inflammation control. Swiss research on fat burning: University of Basel scientists find a beta2-agonist can boost whole-body energy use without activating brown fat, challenging assumptions about how thermogenesis works in humans. Claims triage in Switzerland: VitalityLife and Swiss Re’s PromiseXP go live to route life-claims for faster assessment while keeping human decision-makers in charge. Public health & safety: Swiss police report five deaths and 40 injuries after a bus crash in the eastern Swiss Alps, with details on victims’ backgrounds emerging. Wellness lifestyle: A guide to managing headaches via nutrition spotlights hydration, stable blood sugar, anti-inflammatory foods and nutrients like magnesium and riboflavin.

Prenatal medicine watch: A Danish study reports that acetaminophen (Tylenol/paracetamol) exposure in pregnancy was linked to smaller ovaries and uteruses and fewer ovarian follicles in daughters, with lower anti-Müllerian hormone; researchers stress it doesn’t prove causation and call for longer follow-up. Public health & environment: Swiss researchers estimate microplastics entering the environment from wastewater treatment plants and say better sampling now gives more reliable national figures, with ultrafine plastics also coming from the air. Climate & forecasting: ETH Zurich researchers are training AI on large NASA climate datasets to speed up natural-disaster forecasting and improve early hazard detection. Health system tech: VitalityLife has rolled out Swiss Re’s PromiseXP to triage life-claims faster while keeping human assessors in charge. Safety in Switzerland: A Dutch tour bus crash in the Swiss Alps killed five people (all over 70) and injured 40; authorities are still checking factors like guardrails and seatbelt use.

Prenatal medicine under scrutiny: A Danish study links acetaminophen (Tylenol) use in pregnancy to smaller reproductive organs in daughters, including ~40% smaller ovarian volume and fewer ovarian follicles, with researchers urging longer follow-up and noting it doesn’t prove cause. Vision genetics advance: Scientists report a newly defined late-onset retinal degeneration tied to EFEMP1 gene variants, affecting peripheral and night vision, published in JAMA Ophthalmology. Cancer drug update with Swiss ties: AstraZeneca’s breast-cancer pill camizestrant (Etcamah) missed its main trial goal for progression-free survival, echoing a prior Roche failure; the setback is described as “manageable.” Public health policy debate: UK MPs rejected a bill to legalise assisted dying for the terminally ill, despite earlier Commons approval. Swiss health-adjacent environment: Switzerland’s tax-cut vote in Vaud (12% cut) is set for Sept. 27, with supporters citing purchasing power and opponents warning of budget strain. Health & safety in the news: Reports also highlight multiple serious bus crashes in Switzerland, with medics responding.

Alpine Emergency: A Dutch tour bus overturned in eastern Switzerland near Susch/Zernez, killing 5 and injuring 40 (3 serious, 7 moderate, 30 minor). Rescue teams used seven helicopters and 13 ambulances; authorities say the investigation is ongoing and victims’ identities are still being confirmed. Cardiovascular Nutrition: A new heart-health message is gaining traction: focus on protective, nutrient-rich foods. The report highlights plant staples such as black beans, edamame, Swiss chard, carrots, and plant sterols as ways to support LDL cholesterol, blood pressure, and overall metabolic health. Assisted Dying Cross-Border Debate: In the UK, MPs rejected the Terminally Ill Adults (End of Life) Bill by 286 to 270, while Dame Esther Rantzen says she’s too physically fragile to travel to Dignitas in Switzerland. Pharma Governance Watch: Novartis faces renewed investor pressure after back-to-back Phase 3 trial setbacks, with calls for stronger board oversight of acquisitions and deal scrutiny. Workplace Health & Pay: Switzerland’s bank employees’ association is pushing for a 2.5% wage increase, citing purchasing-power losses and rising health insurance premiums.

Swiss Road Safety: Multiple deaths and injuries were reported after a Dutch tour coach overturned on a mountain road near Susch in Graubünden (Engadine valley), with helicopters and paramedics responding and a hotline set up for relatives. End-of-Life Debate in Switzerland: UK broadcaster Dame Esther Rantzen says she’s too physically fragile to travel to Switzerland for an assisted death at Dignitas, calling the UK’s current rules “messy and cruel” after missing what she believed was her last chance. Cardiovascular Nutrition: A new nutrition push argues heart health is shifting toward proactive, protective foods—highlighting beans, edamame, Swiss chard, carrots/plant sterols, and other nutrient-rich staples. Swiss Pharma Governance: Novartis faces renewed investor pressure after back-to-back late-stage trial setbacks, with a major shareholder calling for a board shake-up and tighter oversight of acquisitions. Public Health & Prevention: Research links early-life air pollution to slower lung growth in children with inherited COPD risk, reinforcing the need for cleaner air protections. Health Policy Watch: India’s proposed tougher food warning labels (sugar, salt, saturated fat) is reigniting debate about processed-food dependence and diabetes risk. Breast Cancer Manufacturing: Saidal and Roche signed a partnership to localize breast cancer medicine production in Algeria, reflecting ongoing pharma supply-chain expansion.

Food Safety & Packaging: A Swiss nonprofit warns that many food-contact chemicals still lack safety data, and that “chemical whack-a-mole” replacements may carry similar risks. Critical Care Tech: Hamilton Medical and Etiometry are partnering to bring AI-supported respiratory intelligence to ICU teams using ventilator data, aiming to improve bedside decisions for mechanically ventilated patients. Assisted Dying Debate: UK campaigners and patients are pushing MPs to pass the assisted dying bill again, with high-profile advocates describing personal stakes and concerns about access and timing. Swiss Pharma Watch: Novartis faces renewed pressure after a late-stage trial failure for del-desiran in myotonic dystrophy, adding to dealmaking scrutiny. Health & Environment: New reporting highlights low levels of microplastics entering Switzerland’s environment from wastewater treatment plants, alongside broader findings on microplastics in soil and water. Workforce & Training: A piece on Switzerland’s apprenticeship model spotlights how vocational training can help build the skilled workforce needed for health and life-science industries. Nazi Files: Switzerland published and unsealed intelligence material on Josef Mengele, renewing attention on historical medical atrocities and accountability.

Suicide prevention in primary care: GP surgeries in the UK are rolling out suicide-prevention awareness packs with Zurich Insurance UK, Samaritans and local partners, aiming to help patients find support before a crisis. Pregnancy medication and fertility questions: A Danish study links prenatal Tylenol/paracetamol exposure to smaller ovaries and wombs in daughters, with researchers stressing it doesn’t prove cause and calling for longer follow-up. Surgery case highlights reconstruction limits: Surgeons at Luzerner Kantonsspital report a rare breast-reconstruction situation where the expected latissimus dorsi muscle was absent, forcing a different approach. Mental health and therapy spotlight: Actor Henry Winkler says long-term talk therapy helped him “empty” distressing thoughts and improve his wellbeing. Health system pressure abroad: US hospitals continue to exit Medicare Advantage deals over administrative barriers and reimbursement issues, with 29 systems dropping plans in 2026. Public health and environment: Coverage also points to Europe’s heat becoming a health crisis and ongoing plastics treaty debates tied to human health risks.

Fusion & Industry: Proxima Fusion and Lower Saxony signed an MoU to build Europe’s first large-scale high-temperature superconducting (HTS) tape facility, with about €140m planned through 2029—an enabling step for more compact fusion power systems. Animal Health: France reported rapid spread of “European Shamonda” among dairy cattle, now in 22 departments, with warnings about risks for pregnant animals and miscarriages/birth defects. Cereal Disease & Food Security: Syngenta and Lyon-based Amoéba expanded their biofungicide deal, giving Syngenta exclusive distribution across EU-27 plus the UK, Ukraine and Switzerland to target septoria and yellow rust. Cardiology Tech Funding: Implicity (Paris) raised €35m to scale AI-driven cardiac remote monitoring and improve heart-failure prediction. Nursing Workforce: A Geneva-based evidence brief argues nursing shortages won’t be fixed by recruitment alone; retention depends on working conditions, pay, respect and career growth. Swiss Policy & Health Access: Liechtenstein’s parliament backed an abortion initiative for the first 12 weeks, but the hereditary prince’s veto still blocks it. Clinical Pipeline Watch: Novartis’ del-desiran Phase 3 in myotonic dystrophy type 1 missed its main goal, delaying a potential first approved treatment. Public Health & Safety: The 2026 Ig Nobel ceremony in Zurich highlighted splash-proof urinal design and other quirky research—an odd reminder that health tech can start anywhere.

Reproductive Health: A new study reports that prenatal Tylenol/paracetamol exposure may be linked with smaller ovaries, fewer ovarian follicles, smaller uteruses and lower reproductive hormone levels in baby girls—researchers stress it’s observational and not proof of cause. Clinical Research (Switzerland): University of Geneva scientists say they’ve restored a defective airway protective barrier in cystic fibrosis by correcting abnormal connexin 43 activity, using molecules already in clinical trials elsewhere. Drug Watch (Swiss pharma): Novartis shares slid after its acquired muscle-wasting drug del-desiran missed a key Phase III goal in myotonic dystrophy type 1, adding pressure to its pipeline and deal strategy. Air Quality & Childhood Health (Switzerland): Swiss researchers found genetic COPD risk in children tracks with slower lung growth specifically where air pollution was highest. Public Health & Safety: A Swiss case report describes a sewing needle lodged in the larynx after accidental swallowing, initially mistaken for stroke symptoms—highlighting the need for fast imaging. Wellness & Lifestyle: The Ig Nobel Prizes returned to Zurich, awarding research on the aerodynamics of nose blowing and other odd-but-serious science.

Swiss health & policy: Switzerland’s Federal Office of Sport reports a drop in soldiers’ fitness-test scores since 2006 (74.2 to 70.4), even as self-rated fitness rose (40% to 56%), with officials pointing to overestimation and training that may not match army test skills. Air quality & lung health: A Swiss birth-cohort analysis links higher genetic risk for COPD to slower lung growth by age six only in children exposed to the highest air pollution, underscoring how environment can flip genetic risk. Child respiratory exposure: A European classroom study finds higher levels of common soil bacteria in dust are associated with slightly lower lung function in children, though it doesn’t prove the bacteria cause the effect. Mental health meds: A review in The Lancet finds antidepressants vary widely in physical side effects, including weight and blood-pressure changes—highlighting why doctors should discuss bodily risks up front. Swiss pharma watch: Novartis shares slide after another late-stage setback (del-desiran in myotonic dystrophy), adding pressure after prior trial failures. Rare disease progress (Swiss biotech): Pharvaris reports strong Phase 3 results for deucrictibant prophylaxis in hereditary angioedema, setting up potential marketing applications. Nutrition & care: Fresenius launches “NutriChef,” real-food-based enteral nutrition for medical supervision, including in Switzerland. Digital sovereignty: Switzerland pilots moving 3,000 government devices from Microsoft 365 toward open-source document tools, aiming for broader rollout by end-2027.

Soil Health in Switzerland: Researchers at the University of Zurich and Agroscope used a citizen-science “underwear burial” experiment, placing 2,000 pairs of cotton underwear at about 1,000 Swiss sites for two months to track how active local soil microbes are. Food Safety Watch: France reported 81 Salmonella cases linked to contaminated pumpkin seeds, with investigations ongoing and recalls/withdrawals affecting products sold via Grand Frais and other retailers. Parkinson’s Drug Pipeline: WHO says dengue still lacks a specific treatment, while a separate WHO review finds only one dengue drug candidate has reached late-stage trials—highlighting how hard it is to turn targets into therapies. Swiss Health & Care Careers: UNITAR and Empower School of Health ran the first Youth Career Accelerator in Health at the Palais des Nations, connecting participants with Swiss hospitals and pharma/biotech players. Rare Medical Case: Doctors in Lausanne reported a West African green mamba bite in a Swiss patient, leading to neurotoxic symptoms and respiratory failure—rare in Europe, but rising with exotic pet ownership. Public Health & Policy: Switzerland is moving toward a national ban on conversion practices, with lawmakers opening the door to wider restrictions.

Public Health & Safety (Kids on the road): A Swiss survey for the Transport and Environment Association finds 41% of parents of children aged 4–7 think the walk to school is dangerous, with 85% of kids crossing roads where speeds are 50 km/h or higher; the group urges safer footpaths, lower speed limits, better crossings, enforcement, and “walking bus” schemes. Cardiology & Pharma (Novartis setbacks): Novartis faces another blow as its late-stage heart drug pelacarsen lowered lipoprotein(a) risk but failed to reduce heart attacks, strokes, or deaths; the news follows recent trial pauses tied to cell-therapy deaths. Health Tech & Access (Swiss digital identity): Procivis expands EUDI Wallet interoperability by adding France to its issuer/verifier testing environment, supporting cross-border credential use as EU countries race toward end-2026 wallet availability. Cancer Survivorship (Activity patterns): A new study maps how childhood cancer survivors’ physical activity varies across the week, highlighting weekend drops and differences between adolescent and adult survivors—aimed at improving long-term care. Climate & Health (Heat impacts): Coverage links Europe’s extreme heat to wider health and energy risks, noting nuclear plant cutbacks in countries including Switzerland and calling for faster climate and energy transitions. Policy & Care (Assisted dying in the spotlight): UK debate continues around assisted dying legislation, with renewed arguments about safeguards and democratic choice.

Assisted dying debate: France’s new “right to aid in dying” law is hailed as a step forward, but advocates say it’s still too restrictive, with eligibility tied to advanced/terminal illness and unbearable suffering. Early lung health: Swiss-led research at the ERS links higher genetic COPD risk in children to reduced lung function growth by age six—especially when air pollution exposure is high. School air quality: Another ERS study reports that common bacteria in classroom dust (including Streptomyces and Mycobacterium) are associated with reduced lung function in children, raising questions about how schools can be kept healthier. Care access in custody: UN experts warn that a Yemen UN staffer with Crohn’s disease and serious complications is being denied specialist medical care while detained. Digital health rehab: A review finds game-based telerehabilitation for multiple sclerosis appears safe and well tolerated at home, with the most consistent gains in balance and postural control. Swiss policy watch: Switzerland is moving toward a national ban on conversion practices. Public health & climate: UN reporting says the 1.5°C warming goal is now “no longer avoidable,” shifting focus to preparing for impacts.

School Air & Lung Health: New ERS research links bacteria in classroom dust (notably Streptomyces and Mycobacterium) with reduced lung function growth in children, pointing to cleaner school environments as a public-health priority. Early Alzheimer’s Prevention: A UK-led international trial will offer the Swiss-developed drug Trontinemab to people without memory loss but at high risk, using blood tests for the p-tau217 marker to target prevention before symptoms. COPD Risk in Childhood: Swiss birth-cohort data presented at ERS found COPD genetic risk tracks with weaker lung function growth from infancy to age 6—especially in children exposed to higher air pollution. Blood Supply Spotlight: Fresenius Kabi and AABB mark Blood Collectors Week (Sept 6–12) to recognize the staff behind safe, reliable blood collection. Heat as a Health Crisis: Coverage highlights Europe’s extreme heat toll and warns that heat is becoming a persistent medical challenge, not just a seasonal spike. El Niño Weather Watch: The WMO says El Niño is likely to strengthen into 2027, raising risks of extreme drought, flooding, and storms. Swiss Health Tech/Trials: Roivant will present Phase 2 PHocus results for mosliciguat in PH-ILD at ERS Congress (Sept 8).

Alzheimer’s Prevention Trial (Europe/Swiss link): Roche-developed trontinemab (aimed at amyloid plaques) is set to be tested in a unique European trial for people without memory-loss symptoms but at higher risk, with UK sites recruiting about 1,600 adults aged 55–80 and using blood tests for p-tau217 to select participants. Swiss Pharma Deal Watch: Novartis’ reported $2B+ acquisition of London-based Myricx is drawing attention from Australian biotech investors after early-stage backers and super funds received more than $300M from the deal. Hospital Strategy (US, not Switzerland but health-system relevant): WakeMed and Atrium Health announced a strategic combination that would bring WakeMed into Atrium Health while keeping WakeMed as a private nonprofit with local governance. Public Health/Wellness Access (GLP-1 generics): As GLP-1 weight-loss patents begin to expire, generic versions are expanding—potentially improving access in systems like the NHS, though availability and equity concerns remain. Assisted Dying Debate (policy): UK political coverage highlights renewed pressure for “watertight safeguards” as MPs debate assisted dying legislation, with Switzerland referenced via the “fly to Switzerland” accounts in the reporting.